Benefit/risk profile of drotrecogin alfa (activated) in surgical patients with severe sepsis
- 1 September 2004
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 188 (3) , 212-220
- https://doi.org/10.1016/j.amjsurg.2004.06.008
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- HOSPITAL AND FOLLOW-UP COSTS IN A SEVERE SEPSIS MANAGED CARE POPULATIONCritical Care Medicine, 2002
- Continuing Challenges of Sepsis ResearchPublished by American Medical Association (AMA) ,2001
- Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of careCritical Care Medicine, 2001
- Animal Models of SepsisJournal of Investigative Surgery, 2001
- Management of bacterial complications in critically ill patients: surgical wound and catheter-related infectionsDiagnostic Microbiology and Infectious Disease, 1999
- Anti-inflammatory therapies to treat sepsis and septic shockCritical Care Medicine, 1997
- Development of Multiple Organ Dysfunction Syndrome in Critically Ill Patients With Perforated ViscusArchives of Surgery, 1996
- Exploratory Laparotomy for Potential Abdominal Sepsis in Patients With Multiple-Organ FailureArchives of Surgery, 1983
- Multiple System Organ FailureArchives of Surgery, 1980
- Multiple, Progressive, or Sequential Systems FailureArchives of Surgery, 1975